Not applicableStudy completedNCT01338740What this trial is testingSwitching From Adalimumab to InfliximabWho this might be right forCrohn's Disease University Hospital, Ghent 21
Testing effectiveness (Phase 2)Study completedNCT02365649What this trial is testingA Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF TherapyWho this might be right forCrohn's Disease AbbVie 220
Testing effectiveness (Phase 2)Study completedNCT01090154What this trial is testingStudy of Cimzia for the Treatment of Ulcerative ColitisWho this might be right forUlcerative Colitis University of Washington 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT05668013What this trial is testingEvaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's DiseaseWho this might be right forCrohn DiseaseColitis, Ulcerative Teva Branded Pharmaceutical Products R&D LLC 247
Large-scale testing (Phase 3)Study completedNCT02171429What this trial is testingA Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) InhibitorsWho this might be right forUlcerative Colitis Hoffmann-La Roche 358
Early research (Phase 1)Study completedNCT01659762What this trial is testingA Phase I Study Evaluating Autologous Bone Marrow Derived Mesenchymal Stromal for Crohn's Disease.Who this might be right forCrohn's Disease Emory University 16
Testing effectiveness (Phase 2)Ended earlyNCT03650413What this trial is testingAn Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's DiseaseWho this might be right forUlcerative ColitisCrohn's Disease Genentech, Inc. 143
Testing effectiveness (Phase 2)Study completedNCT05377580What this trial is testingEvaluate IBI112 in the Treatment of Moderate to Severe Active Ulcerative ColitisWho this might be right forUlcerative Colitis (UC) Innovent Biologics (Suzhou) Co. Ltd. 150
Testing effectiveness (Phase 2)Study completedNCT05013905What this trial is testingA Phase 2a Safety and Efficacy Open-Label Study of Tulisokibart (MK-7240/PRA023) in Participants With Moderately to Severely Active Crohn's Disease (MK-7240-006)Who this might be right forCrohn Disease Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 55
Early research (Phase 1)Study completedNCT02818686What this trial is testingTD-1473 for Active Ulcerative Colitis (UC)Who this might be right forUlcerative Colitis, Active ModerateUlcerative Colitis, Active Severe Theravance Biopharma 40
Early research (Phase 1)Study completedNCT01847170What this trial is testingImpact of Fecal Biotherapy (FBT) on Microbial Diversity in Patients With Moderate to Severe Inflammatory Bowel DiseaseWho this might be right forCrohn's Disease Beth Israel Deaconess Medical Center 22
Large-scale testing (Phase 3)Study completedNCT03524092What this trial is testingA Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative ColitisWho this might be right forUlcerative Colitis Eli Lilly and Company 1,328
Testing effectiveness (Phase 2)Study completedNCT00740103What this trial is testingLong-term Study of Semapimod (CNI-1493) for Treatment of Crohn's DiseaseWho this might be right forCrohn's Disease Ferring Pharmaceuticals 119
Post-approval studies (Phase 4)Ended earlyNCT02392286What this trial is testingCorticosteroid Dosage for Crohn's Disease FlareWho this might be right forCrohn's DiseaseInflammatory Bowel Disease Yale University 15
Not applicableUnknownNCT02277470What this trial is testingStudy of the Pharmacokinetics of Golimumab in Moderate to Severe Ulcerative ColitisWho this might be right forUlcerative Colitis Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 20
Testing effectiveness (Phase 2)Ended earlyNCT03870334What this trial is testingEfficacy and Safety of Oral BT-11 in Moderate to Severe Crohn's DiseaseWho this might be right forCrohn's Disease NImmune Biopharma 27
Large-scale testing (Phase 3)Study completedNCT05507216What this trial is testingABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2Who this might be right forUlcerative Colitis Abivax S.A. 636
Large-scale testing (Phase 3)Looking for participantsNCT04844606What this trial is testingA Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)Who this might be right forUlcerative ColitisUlcerative Colitis ChronicInflammatory Bowel Diseases+1 more Eli Lilly and Company 150
Not applicableUnknownNCT06469424What this trial is testingAn Active Surveillance, Post-Authorization Study to Characterize the Safety of Tofacitinib in Patients With Moderately to Severely Active Ulcerative Colitis in the Real-World Setting Using Data From the United Registries for Clinical Assessment and Research (UR-CARE) in the European Union (EU)Who this might be right forUlcerative Colitis Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa 104
Testing effectiveness (Phase 2)Looking for participantsNCT07483099What this trial is testingLY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's DiseaseWho this might be right forCrohn Disease Eli Lilly and Company 60